BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 24518594)

  • 1. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review.
    Grønhøj Larsen C; Gyldenløve M; Jensen DH; Therkildsen MH; Kiss K; Norrild B; Konge L; von Buchwald C
    Br J Cancer; 2014 Mar; 110(6):1587-94. PubMed ID: 24518594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
    Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
    J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.
    Donà MG; Spriano G; Pichi B; Rollo F; Laquintana V; Covello R; Pellini R; Giuliani M; Pescarmona E; Benevolo M
    Future Microbiol; 2015; 10(8):1283-91. PubMed ID: 26228531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
    Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
    Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
    Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
    Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.
    Jouhi L; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Hagström J
    Cancer Immunol Immunother; 2017 Dec; 66(12):1619-1629. PubMed ID: 28856441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer.
    Matsumoto F; Fujimaki M; Ohba S; Kojima M; Yokoyama J; Ikeda K
    Head Neck; 2015 Jul; 37(7):977-81. PubMed ID: 24700733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site.
    Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T
    ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.
    Doxtader EE; Katzenstein AL
    Hum Pathol; 2012 Mar; 43(3):327-32. PubMed ID: 21840041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV status of oropharyngeal cancer by combination HPV DNA/p16 testing: biological relevance of discordant results.
    Hong A; Jones D; Chatfield M; Lee CS; Zhang M; Clark J; Elliott M; Harnett G; Milross C; Rose B
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S450-8. PubMed ID: 23208131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice.
    Thavaraj S; Stokes A; Guerra E; Bible J; Halligan E; Long A; Okpokam A; Sloan P; Odell E; Robinson M
    J Clin Pathol; 2011 Apr; 64(4):308-12. PubMed ID: 21345874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
    Shi W; Kato H; Perez-Ordonez B; Pintilie M; Huang S; Hui A; O'Sullivan B; Waldron J; Cummings B; Kim J; Ringash J; Dawson LA; Gullane P; Siu L; Gillison M; Liu FF
    J Clin Oncol; 2009 Dec; 27(36):6213-21. PubMed ID: 19884544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
    Kumar B; Brown NV; Swanson BJ; Schmitt AC; Old M; Ozer E; Agrawal A; Schuller DE; Teknos TN; Kumar P
    Oncotarget; 2016 Apr; 7(14):18665-77. PubMed ID: 26919244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.